
    
      In this study, a randomized controlled study was conducted to compare the efficacy, safety
      and economy of CZP and glucocorticoids combined with hydroxychloroquine in the treatment of
      RA patients who consider pregnancy. Informed consent must be obtained for the patients to be
      screened.

      Random method: central random.

      Blinding method: assessor and data analyst blindness.

      Follow-up: every 4 week.

      First endpoint: 24 week.

      Second endpoint: 52 week.

      Safety endpoint: 24 weeks postpartum.

      Missing data: core data related to treatment and disease activity are not allowed to be
      missing, and other data are supplemented by the last observation value.
    
  